DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 67 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -52.9% | 2,889 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +112.5% | 2,889 | +11.9% | 0.00% | – |
| Q2 2016 | $8,000 | -97.2% | 2,582 | -95.1% | 0.00% | – |
| Q1 2016 | $284,000 | -54.0% | 52,917 | +1.8% | 0.00% | -100.0% |
| Q4 2015 | $617,000 | +44.8% | 51,961 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $426,000 | -42.6% | 51,886 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $742,000 | +195.6% | 53,197 | +408.7% | 0.00% | – |
| Q1 2015 | $251,000 | +42.6% | 10,458 | -2.2% | 0.00% | – |
| Q4 2014 | $176,000 | +29.4% | 10,695 | 0.0% | 0.00% | – |
| Q3 2014 | $136,000 | -44.0% | 10,695 | -0.6% | 0.00% | – |
| Q2 2014 | $243,000 | -12.6% | 10,760 | +9.3% | 0.00% | – |
| Q1 2014 | $278,000 | – | 9,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
| Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
| EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
| RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
| BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
| Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
| Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
| DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
| EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |